<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03212443</url>
  </required_header>
  <id_info>
    <org_study_id>Diskapi4</org_study_id>
    <nct_id>NCT03212443</nct_id>
  </id_info>
  <brief_title>Combined Suprascapular and Axillary Nerve Blocks for Arthroscopic Shoulder Surgery</brief_title>
  <official_title>Combined Suprascapular and Axillary Nerve Blocks for Sevoflurane Consumption and Postoperative Analgesia in Arthroscopic Shoulder Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arthroscopic shoulder surgery is associated with severe pain postoperatively. Regional nerve
      block adding to general anesthesia might improve the quality of postoperative analgesia. The
      aim of the study is to compare the subacromial local anesthetic infiltration and the
      suprascapular-axillary nerve blocks combination for intraoperative sevoflurane consumption,
      postoperative analgesia and analgesic consumption.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After informed consent and with ethics approval, 60 ASA 2-3 patients scheduled for elective
      arthroscopic shoulder surgery will be included in this study. Patient will be divided to two
      groups by using computer -generated list for randomization. In group A, the surgeon will
      apply 20 ml of 0.250% bupivacaine to the subacromial region at the end of the procedure. In
      Group B, suprascapular (10 ml of 0.250% bupivacaine ) and axillary block (10 ml of 0.250%
      bupivacaine) will be performed with ultrasound and nerve stimulator guidance before induction
      of anesthesia. In all patients after standard and BIS (Bi spectral index) monitorization
      general anesthesia will be induced with remifentanil (10mcg iv), propofol (2.5 mg/kg iv) and
      rocuronium (0.5mg/kg iv). After intubation, anesthesia will be maintained with 50% O2 and N2O
      mixture. Hemodynamic parameters, BIS values, end-tidal sevoflurane consumption will be
      recorded by blind investigator. Postoperative visual analog scale (VAS) values, postoperative
      analgesic consumption (Tramadol, patient controlled analgesia), complications will be
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 10, 2017</start_date>
  <completion_date type="Anticipated">November 10, 2017</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative VAS scores</measure>
    <time_frame>Through postoperative period, an avarage of 30 minutes</time_frame>
    <description>Ranging from 0: no pain to 10: worst pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sevoflurane consumption</measure>
    <time_frame>5th, 10th,20th,30th,40th,50th minutes after induction of anesthesia</time_frame>
    <description>End tidal sevoflurane concentration values assesment during the surgery</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Bleeding assesment</measure>
    <time_frame>5th, 10th,20th,30th,40th,50th minutes after induction of anesthesia</time_frame>
    <description>stage1: Good surgical visualization, Stage 2: Moderate bleeding, Stage 3: Severe bleeding, bad surgical visualization</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Arthroscopic Shoulder Surgery</condition>
  <condition>Suprascapular Nerve Block</condition>
  <condition>Axillary Nerve Block</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>In group A, the surgeon will apply 20 ml of 0.250% bupivacaine to the subacromial region at the end of the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In Group B, suprascapular (10 ml of 0.250% bupivacaine ) and axillary block (10 ml of 0.250% bupivacaine) will be performed with ultrasound and nerve stimulator guidance before induction of anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Suprascapular nerve- axillary nerve block combination</intervention_name>
    <description>In Group B, suprascapular (10 ml of 0.250% bupivacaine ) and axillary block (10 ml of 0.250% bupivacaine) will be performed with ultrasound and nerve stimulator guidance before induction of anesthesia</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subacromial infiltration</intervention_name>
    <description>In group A, the surgeon will apply 20 ml of 0.250% bupivacaine to the subacromial region at the end of the procedure</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American society of anesthesia physical status (ASA) 1,2 patients

          -  Elective arthroscopic shoulder surgery

        Exclusion Criteria:

          -  ASA 3,4 patients

          -  Coagulation abnormality

          -  Body mass index &gt;30

          -  Preexisting neurological deficit Local anesthetic allergy history Diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Derya Ozkan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>derya ozkan</last_name>
    <phone>00903125962580</phone>
    <email>derya_z@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Derya Ozkan</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>derya ozkan</last_name>
      <phone>00903125962580</phone>
      <email>derya_z@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Sevtap Cemaloglu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Dhir S, Sondekoppam RV, Sharma R, Ganapathy S, Athwal GS. A Comparison of Combined Suprascapular and Axillary Nerve Blocks to Interscalene Nerve Block for Analgesia in Arthroscopic Shoulder Surgery: An Equivalence Study. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):564-71. doi: 10.1097/AAP.0000000000000436.</citation>
    <PMID>27380105</PMID>
  </results_reference>
  <results_reference>
    <citation>Ritchie ED, Tong D, Chung F, Norris AM, Miniaci A, Vairavanathan SD. Suprascapular nerve block for postoperative pain relief in arthroscopic shoulder surgery: a new modality? Anesth Analg. 1997 Jun;84(6):1306-12.</citation>
    <PMID>9174311</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>July 31, 2017</last_update_submitted>
  <last_update_submitted_qc>July 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>derya Ã¶zkan</investigator_full_name>
    <investigator_title>Associated professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

